What is the 13F Pro Quality Score for SKIN?

13F Pro ranks SkinHealth Systems Inc. (SKIN) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View SKIN's current score at https://13fpro.ai/company/SKIN (free sign-up required for the full ranking).

Which hedge funds own the most SKIN stock?

Based on the most recent Form 13F-HR filings on SEC EDGAR, the largest reported institutional holders of SKIN include Capricorn Fund Managers Ltd, FMR, BlackRock,. Holdings are reported quarterly within 45 days of quarter-end and updated on https://13fpro.ai/company/SKIN as soon as new 13F filings post.

Where does 13F Pro source SKIN data?

All SkinHealth Systems Inc. fundamentals and ownership data come directly from SEC EDGAR. SkinHealth Systems Inc. files with the SEC under CIK 1818093. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

What sector is SKIN in?

SkinHealth Systems Inc. (SKIN) is classified in the Healthcare sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/healthcare.

How often is SKIN research updated on 13F Pro?

SKIN's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

SkinHealth Systems Inc.(SKIN)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Healthcare →Nasdaqsmall

Institutional-grade research for retail investors

SEC EDGAR: CIK 1818093 SKIN stock profile & AI dashboard →

13F Pro Quality Score

26.9/100

Rank #2,600 of 2,962 stocks

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Revenue Growth

5.9/100

Profitability

19.3/100

Balance Sheet

21.7/100

Earnings Quality

59.1/100

Free Cash Flow

48.4/100

Institutional Flow

5.1/100

Revenue Scale

28.8/100

Dilution Risk

24.9/100

Email me the moment this company reports earnings

AI Research Report

Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.

Upgrade to Pro

Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.

Why SKIN Scores 27/100

exact factor attribution · 2026-09-11

SKIN's composite is held back by revenue growth and profitability. Bars show each factor's exact push vs. a median company, using the same weights the ranking engine applies.

Earnings quality

+0.9 pts

59th pct

Free cash flow

-0.2 pts

48th pct

Earnings growth

-0.8 pts

34th pct

Shareholder dilution

-1.3 pts

25th pct

Institutional flow

-2.3 pts

5th pct

Capital efficiency

-2.8 pts

22th pct

Scale

-3.2 pts

29th pct

Profitability

-4.6 pts

19th pct

Revenue growth

-8.8 pts

6th pct

Latest change (2026-08-07): 32 → 28 · ↓ Profit margin 44→20

Factor percentiles are cross-sectional ranks across the ~2,800-stock scored universe, computed from SEC EDGAR filings. Not investment advice.

SKIN Stock Analysis & AI Quality Score

Data updated 2026-09-11

AI stock analysis and institutional research for SkinHealth Systems Inc. (SKIN), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores SKIN at 26.9/100 on a 32-signal composite quality model, placing it at rank #2,600 of 2,962 stocks — the bottom half of the AI-ranked universe. Areas of concern include institutional flow (5.1) and revenue growth (5.9), which score below median versus the broader universe. Shareholder dilution risk is elevated at 24.9/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), SkinHealth Systems Inc. reports quarterly revenue of $72.1M, net income of $-2.7M, an operating margin of 5.0%. Top institutional holders of SKIN by reported 13-F value include Capricorn Fund Managers Ltd, FMR, BlackRock, based on the most recent SEC filings. SKIN trades on the Nasdaq exchange and files with the SEC under CIK 1818093. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate SKIN daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for SkinHealth Systems Inc. directly from SEC EDGAR. SkinHealth Systems Inc.'s 13F Pro composite quality score has ranged between 22 and 52 since 2022, currently 26.9 — an improving long-term trajectory across 64 quarterly and live scoring snapshots.

Revenue

Q2 2026

$72.1M

Net Income

Q2 2026

$-2.7M

Free Cash Flow

Q2 2026

$2.2M

Operating Margin

Q2 2026

5.0%

ROIC

Q2 2026

25.7%

Period

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro

Revenue

-10.0% YoY

$300.8MFY 2025

FY22 $365.9MFY23 $398.0MFY24 $334.3MFY25 $300.8M

Net Income

+67.3% YoY

$-9.5MFY 2025

FY22 $44.2MFY23 $-100.1MFY24 $-29.1MFY25 $-9.5M

Operating Income

+69.3% YoY

$-20.8MFY 2025

FY22 $-25.8MFY23 $-130.9MFY24 $-67.8MFY25 $-20.8M

EPS (Diluted)

+55.6% YoY

$-0.16FY 2025

FY22 $-0.23FY23 $-0.76FY24 $-0.36FY25 $-0.16

Total Assets

-27.1% YoY

$499.8MFY 2025

FY22 $1.00BFY23 $929.1MFY24 $685.7MFY25 $499.8M

Total Debt

—FY 2025

FY22 —FY23 —FY24 $552.2MFY25 —

Op. Cash Flow

+132.3% YoY

$37.5MFY 2025

FY22 $-106.6MFY23 $21.8MFY24 $16.1MFY25 $37.5M

Free Cash Flow

+141.8% YoY

$37.2MFY 2025

FY22 $-117.4MFY23 $17.9MFY24 $15.4MFY25 $37.2M

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Revenue	$300.8M -10.0%	$334.3M -16.0%	$398.0M +8.8%	$365.9M +40.7%	$260.1M +118.4%	$119.1M
Net Income	$-9.5M +67.3%	$-29.1M +70.9%	$-100.1M -326.4%	$44.2M +111.7%	$-378.8M -1198.2%	$-29.2M
Operating Income	$-20.8M +69.3%	$-67.8M +48.2%	$-130.9M -406.6%	$-25.8M +35.3%	$-39.9M -132.4%	$-17.2M
EPS (Diluted)	$-0.16 +55.6%	$-0.36 +52.6%	$-0.76 -230.4%	$-0.23 +93.8%	$-3.71 -336.5%	$-0.85
Total Assets	$499.8M -27.1%	$685.7M -26.2%	$929.1M -7.4%	$1.00B -17.7%	$1.22B +447.0%	$222.8M
Total Debt	—	$552.2M	—	—	—	—
Operating Cash Flow	$37.5M +132.3%	$16.1M -25.8%	$21.8M +120.4%	$-106.6M -275.9%	$-28.4M -128.1%	$-12.4M
Free Cash Flow	$37.2M +141.8%	$15.4M -14.2%	$17.9M +115.3%	$-117.4M -196.9%	$-39.6M -148.2%	$-15.9M

Get alerted when SKIN's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for SkinHealth Systems Inc. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of SKIN

Capricorn Fund Managers Ltd
$15.4M22,276,935 sh
FMR LLC
$7.1M10,201,685 sh
BlackRock, Inc.
$5.9M8,516,203 sh
MILLENNIUM MANAGEMENT LLC
$5.2M7,536,938 sh
UBS Group AG
$2.5M3,542,164 sh
VANGUARD CAPITAL MANAGEMENT LLC
$2.4M3,496,485 sh
Woodline Partners LP
$1.6M2,328,700 sh
Silver Point Capital L.P.
$1.1M1,592,030 sh
D. E. Shaw & Co., Inc.
$991.9K1,432,312 sh
CORBYN INVESTMENT MANAGEMENT INC/MD
$978.8K1,000,000 sh

Fund	Value	Shares
Capricorn Fund Managers Ltd	$15.4M	22,276,935
FMR LLC	$7.1M	10,201,685
BlackRock, Inc.	$5.9M	8,516,203
MILLENNIUM MANAGEMENT LLC	$5.2M	7,536,938
UBS Group AG	$2.5M	3,542,164
VANGUARD CAPITAL MANAGEMENT LLC	$2.4M	3,496,485
Woodline Partners LP	$1.6M	2,328,700
Silver Point Capital L.P.	$1.1M	1,592,030
D. E. Shaw & Co., Inc.	$991.9K	1,432,312
CORBYN INVESTMENT MANAGEMENT INC/MD	$978.8K	1,000,000

Companies Similar to SKIN

Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.

KLC

KinderCare Learning Companies, Inc.

AI score

Similar quality profile · 1 shared holders

Silver Point Capital L.P.

SGHT

Sight Sciences, Inc.

AI score

Similar quality profile · 3 shared holders

JACOBS LEVY EQUITY MANAGEMENT, INC SCS Capital Management LLC Silicon Valley Capital Partners

SRPT

Sarepta Therapeutics, Inc.

AI score

Similar quality profile · 2 shared holders

CORBYN INVESTMENT MANAGEMENT INC/MD Elequin Securities, LLC

TMCI

TREACE MEDICAL CONCEPTS, INC.

AI score

Similar quality profile · 2 shared holders

JACOBS LEVY EQUITY MANAGEMENT, INC MTM Investment Management, LLC

SCLX

Scilex Holding Co

AI score

Similar quality profile · 3 shared holders

JACOBS LEVY EQUITY MANAGEMENT, INC Allied Private Wealth LLC TSFG, LLC

ANIK

Anika Therapeutics, Inc.

AI score

Similar quality profile · 1 shared holders

JACOBS LEVY EQUITY MANAGEMENT, INC

ANGO

ANGIODYNAMICS INC

AI score

Similar quality profile · 1 shared holders

JACOBS LEVY EQUITY MANAGEMENT, INC

FTRE

Fortrea Holdings Inc.

AI score

Similar quality profile · 4 shared holders

PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C.JACOBS LEVY EQUITY MANAGEMENT, INC Cohen Capital Management, Inc.

Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.

More Healthcare Companies

View all Healthcare →

AAPG

ASCENTAGE PHARMA GROUP INTERNATIONAL

AARD

Aardvark Therapeutics, Inc.

ABBV

AbbVie Inc.

ABCL

AbCellera Biologics Inc.

ABEO

ABEONA THERAPEUTICS INC.

ABOS

Acumen Pharmaceuticals, Inc.

ABPWW

Abpro Holdings, Inc.

ABSI

Absci Corp

Put SKIN on your watchlist

Track score changes the day SkinHealth Systems Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is SKIN a good stock to buy?

13F Pro's AI-powered analysis of SkinHealth Systems Inc. (SKIN) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for SKIN are available on the SKIN stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. SKIN is classified as a small company.

Which hedge funds own SKIN?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling SKIN. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of SkinHealth Systems Inc.'s investment landscape.